Dr. Martens plc (LON:DOCS - Get Free Report) shares were up 25.8% on Thursday . The company traded as high as GBX 76 ($1.03) and last traded at GBX 75.40 ($1.02). Approximately 8,364,149 shares traded hands during mid-day trading, an increase of 271% from the average daily volume of 2,253,765 shares. The stock had previously closed at GBX 59.95 ($0.81).
Analyst Upgrades and Downgrades
Separately, Royal Bank of Canada dropped their target price on Dr. Martens from GBX 7,000 ($95.06) to GBX 6,000 ($81.48) and set a "sector perform" rating on the stock in a report on Monday, May 19th.
Check Out Our Latest Analysis on DOCS
Dr. Martens Stock Up 25.8%
The company has a market cap of £731.96 million, a price-to-earnings ratio of 10.69, a P/E/G ratio of 6.40 and a beta of 0.11. The company has a current ratio of 2.85, a quick ratio of 1.13 and a debt-to-equity ratio of 127.27. The business has a fifty day moving average price of GBX 54.24 and a two-hundred day moving average price of GBX 62.52.
Dr. Martens (LON:DOCS - Get Free Report) last released its quarterly earnings data on Thursday, June 5th. The company reported GBX 2.40 ($0.03) EPS for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. On average, equities analysts predict that Dr. Martens plc will post 2.5809394 earnings per share for the current year.
Dr. Martens Cuts Dividend
The business also recently announced a dividend, which was paid on Tuesday, April 8th. Shareholders of record on Thursday, March 6th were given a dividend of GBX 0.85 ($0.01) per share. The ex-dividend date was Thursday, March 6th. This represents a yield of 1.47%. Dr. Martens's payout ratio is currently 42.53%.
Insider Activity
In other news, insider Giles Wilson acquired 32,640 shares of the stock in a transaction that occurred on Tuesday, March 25th. The stock was purchased at an average cost of GBX 54 ($0.73) per share, for a total transaction of £17,625.60 ($23,934.82). Over the last three months, insiders acquired 33,206 shares of company stock valued at $1,792,771. 4.36% of the stock is owned by company insiders.
About Dr. Martens
(
Get Free Report)
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Dr. Martens, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.
While Dr. Martens currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
